AI 聊天

Edwards Lifesciences Corporation

EW · NYSE · USD

85.52 +1.15 (1.36%)

收盤價: Sep 14, 2026, 3:59 PM

85.52 +0.00%

盤後: 5:05 PM

市值
$49.29B
成交量
2.99M
下次財報日期
Oct 29, 2026

Edwards Lifesciences Corporation(EW)股價、分析與資料

內在價值

正在載入內在價值…

分析師預測

股票預測 →

目標價

$84,00 – $110,00

中位數 $101,50 · 18.69% 上漲空間

12個月目標價 · 26 位分析師

分析師共識: 購買

間隔:1D
正在載入K線和訊號…

財務表現

查看財務 →

正在載入...

最新財報

已通報較預期YoY 變更
營收n/an/a
EPS$0,78+$0,04+16.42%

下次財報

收盤後。

估計 · 升級 →

查看財報詳情 →

指標

買價
84.65
市值
49.3B
淨利(ttm)
980M
0.85
1.68
50.9
25.32
P/B (ttm)
4.64
P/S (ttm)
7.56
財報日期
Oct 29, 2026
賣價
86
成交量
2,988,073
20 日平均成交量
4,135,124
開盤價
85.45
前收盤價
84.37
當日區間
85.16 - 86.26
52 週範圍
72.30 - 96.29
分析師
購買
目標價
101.5 (18.69%)
股利
n/a
除息日
n/a

關於 Edwards Lifesciences Corporation

查看公司資料 →
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. Medical Devices · Healthcare

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

類股 Healthcare
IPO 日期 Mar 27, 2000
員工 16,000
證券交易所 NYSE
股票代號 EW